vs
JFrog Ltd（FROG）与PUMA BIOTECHNOLOGY, INC.（PBYI）财务数据对比。点击上方公司名可切换其他公司
JFrog Ltd的季度营收约是PUMA BIOTECHNOLOGY, INC.的1.9倍（$145.3M vs $75.5M），PUMA BIOTECHNOLOGY, INC.同比增速更快（27.7% vs 25.2%），JFrog Ltd自由现金流更多（$49.9M vs $14.4M），过去两年PUMA BIOTECHNOLOGY, INC.的营收复合增速更高（31.3% vs 20.4%）
JFrog Ltd是全球知名的DevOps技术服务商，面向科技、金融、零售、制造等多个行业客户，提供全链路软件发布、制品管理与安全解决方案，助力企业简化云、本地及混合部署环境下的应用开发与交付流程。
彪马生物技术是一家公开上市的生物制药企业，总部位于美国加利福尼亚州洛杉矶，专注于创新药物研发相关业务，在生物制药领域开展研发与商业化运营。
FROG vs PBYI — 直观对比
营收规模更大
FROG
是对方的1.9倍
$75.5M
营收增速更快
PBYI
高出2.5%
25.2%
自由现金流更多
FROG
多$35.5M
$14.4M
两年增速更快
PBYI
近两年复合增速
20.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $145.3M | $75.5M |
| 净利润 | $-15.2M | — |
| 毛利率 | 77.9% | 69.3% |
| 营业利润率 | -14.7% | 22.7% |
| 净利率 | -10.5% | — |
| 营收同比 | 25.2% | 27.7% |
| 净利润同比 | 34.4% | — |
| 每股收益（稀释后） | $-0.13 | $0.26 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收FROGPBYI
| Q4 25 | $145.3M | $75.5M | ||
| Q3 25 | $136.9M | $54.5M | ||
| Q2 25 | $127.2M | $52.4M | ||
| Q1 25 | $122.4M | $46.0M | ||
| Q4 24 | $116.1M | $59.1M | ||
| Q3 24 | $109.1M | $80.5M | ||
| Q2 24 | $103.0M | $47.1M | ||
| Q1 24 | $100.3M | $43.8M |
净利润FROGPBYI
| Q4 25 | $-15.2M | — | ||
| Q3 25 | $-16.4M | $8.8M | ||
| Q2 25 | $-21.7M | $5.9M | ||
| Q1 25 | $-18.5M | $3.0M | ||
| Q4 24 | $-23.2M | — | ||
| Q3 24 | $-22.9M | $20.3M | ||
| Q2 24 | $-14.3M | $-4.5M | ||
| Q1 24 | $-8.8M | $-4.8M |
毛利率FROGPBYI
| Q4 25 | 77.9% | 69.3% | ||
| Q3 25 | 77.4% | 77.7% | ||
| Q2 25 | 76.3% | 76.5% | ||
| Q1 25 | 75.3% | 77.1% | ||
| Q4 24 | 75.4% | 76.4% | ||
| Q3 24 | 75.0% | 63.9% | ||
| Q2 24 | 78.8% | 77.4% | ||
| Q1 24 | 79.5% | 75.5% |
营业利润率FROGPBYI
| Q4 25 | -14.7% | 22.7% | ||
| Q3 25 | -15.8% | 17.6% | ||
| Q2 25 | -20.4% | 12.7% | ||
| Q1 25 | -18.8% | 8.7% | ||
| Q4 24 | -21.9% | 22.6% | ||
| Q3 24 | -27.4% | 27.4% | ||
| Q2 24 | -18.6% | -4.6% | ||
| Q1 24 | -16.6% | -5.3% |
净利率FROGPBYI
| Q4 25 | -10.5% | — | ||
| Q3 25 | -12.0% | 16.2% | ||
| Q2 25 | -17.0% | 11.2% | ||
| Q1 25 | -15.1% | 6.5% | ||
| Q4 24 | -20.0% | — | ||
| Q3 24 | -21.0% | 25.2% | ||
| Q2 24 | -13.9% | -9.6% | ||
| Q1 24 | -8.8% | -11.0% |
每股收益（稀释后）FROGPBYI
| Q4 25 | $-0.13 | $0.26 | ||
| Q3 25 | $-0.14 | $0.17 | ||
| Q2 25 | $-0.19 | $0.12 | ||
| Q1 25 | $-0.16 | $0.06 | ||
| Q4 24 | $-0.21 | $0.40 | ||
| Q3 24 | $-0.21 | $0.41 | ||
| Q2 24 | $-0.13 | $-0.09 | ||
| Q1 24 | $-0.08 | $-0.10 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $704.4M | $97.5M |
| 总债务越低越好 | — | $22.7M |
| 股东权益账面价值 | $887.4M | $130.3M |
| 总资产 | $1.3B | $216.3M |
| 负债/权益比越低杠杆越低 | — | 0.17× |
8季度趋势，按日历期对齐
现金及短期投资FROGPBYI
| Q4 25 | $704.4M | $97.5M | ||
| Q3 25 | $651.1M | $94.4M | ||
| Q2 25 | $611.7M | $96.0M | ||
| Q1 25 | $563.5M | $93.2M | ||
| Q4 24 | $522.0M | $101.0M | ||
| Q3 24 | $467.8M | $96.7M | ||
| Q2 24 | $591.3M | $96.8M | ||
| Q1 24 | $579.6M | $107.2M |
总债务FROGPBYI
| Q4 25 | — | $22.7M | ||
| Q3 25 | — | $34.0M | ||
| Q2 25 | — | $45.3M | ||
| Q1 25 | — | $56.7M | ||
| Q4 24 | — | $68.0M | ||
| Q3 24 | — | $79.3M | ||
| Q2 24 | — | $90.7M | ||
| Q1 24 | — | $102.0M |
股东权益FROGPBYI
| Q4 25 | $887.4M | $130.3M | ||
| Q3 25 | $859.4M | $115.3M | ||
| Q2 25 | $826.5M | $104.7M | ||
| Q1 25 | $800.0M | $97.1M | ||
| Q4 24 | $773.5M | $92.1M | ||
| Q3 24 | $756.2M | $71.1M | ||
| Q2 24 | $721.4M | $48.5M | ||
| Q1 24 | $707.8M | $51.0M |
总资产FROGPBYI
| Q4 25 | $1.3B | $216.3M | ||
| Q3 25 | $1.3B | $202.9M | ||
| Q2 25 | $1.2B | $194.9M | ||
| Q1 25 | $1.2B | $196.2M | ||
| Q4 24 | $1.1B | $213.3M | ||
| Q3 24 | $1.1B | $220.7M | ||
| Q2 24 | $1.0B | $205.0M | ||
| Q1 24 | $997.1M | $214.1M |
负债/权益比FROGPBYI
| Q4 25 | — | 0.17× | ||
| Q3 25 | — | 0.30× | ||
| Q2 25 | — | 0.43× | ||
| Q1 25 | — | 0.58× | ||
| Q4 24 | — | 0.74× | ||
| Q3 24 | — | 1.12× | ||
| Q2 24 | — | 1.87× | ||
| Q1 24 | — | 2.00× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $50.7M | $14.4M |
| 自由现金流经营现金流 - 资本支出 | $49.9M | $14.4M |
| 自由现金流率自由现金流/营收 | 34.3% | 19.1% |
| 资本支出强度资本支出/营收 | 0.6% | 0.0% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $142.3M | $41.7M |
8季度趋势，按日历期对齐
经营现金流FROGPBYI
| Q4 25 | $50.7M | $14.4M | ||
| Q3 25 | $30.2M | $9.7M | ||
| Q2 25 | $36.1M | $14.1M | ||
| Q1 25 | $28.8M | $3.6M | ||
| Q4 24 | $49.1M | $15.6M | ||
| Q3 24 | $27.6M | $11.0M | ||
| Q2 24 | $16.7M | $1.0M | ||
| Q1 24 | $17.5M | $11.2M |
自由现金流FROGPBYI
| Q4 25 | $49.9M | $14.4M | ||
| Q3 25 | $28.8M | $9.7M | ||
| Q2 25 | $35.5M | $14.1M | ||
| Q1 25 | $28.1M | $3.6M | ||
| Q4 24 | $48.5M | $15.6M | ||
| Q3 24 | $26.7M | $11.0M | ||
| Q2 24 | $16.0M | $1.0M | ||
| Q1 24 | $16.6M | — |
自由现金流率FROGPBYI
| Q4 25 | 34.3% | 19.1% | ||
| Q3 25 | 21.0% | 17.7% | ||
| Q2 25 | 27.9% | 26.8% | ||
| Q1 25 | 23.0% | 7.7% | ||
| Q4 24 | 41.8% | 26.4% | ||
| Q3 24 | 24.5% | 13.7% | ||
| Q2 24 | 15.5% | 2.1% | ||
| Q1 24 | 16.6% | — |
资本支出强度FROGPBYI
| Q4 25 | 0.6% | 0.0% | ||
| Q3 25 | 1.0% | 0.0% | ||
| Q2 25 | 0.5% | 0.0% | ||
| Q1 25 | 0.5% | 0.1% | ||
| Q4 24 | 0.5% | 0.0% | ||
| Q3 24 | 0.9% | 0.0% | ||
| Q2 24 | 0.7% | 0.0% | ||
| Q1 24 | 0.8% | 0.0% |
现金转化率FROGPBYI
| Q4 25 | — | — | ||
| Q3 25 | — | 1.10× | ||
| Q2 25 | — | 2.41× | ||
| Q1 25 | — | 1.21× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 0.54× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
